3-n-(2-fluoroethyl)spiperone has been researched along with Depressive Disorder, Major in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artigas, F; Colombo, C; Fazio, F; Galli, L; Gilardi, MC; Gobbo, C; Lucignani, G; Messa, C; Moresco, RM; Rizzo, G; Smeraldi, E; Zanardi, R | 1 |
| Bonfanti, A; Colombo, C; Del Sole, A; Fazio, F; Galli, L; Gobbo, C; Lucca, A; Lucignani, G; Messa, C; Moresco, RM; Smeraldi, E | 1 |
1 trial(s) available for 3-n-(2-fluoroethyl)spiperone and Depressive Disorder, Major
| Article | Year |
|---|---|
Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Depressive Disorder, Major; Female; Fluorine Radioisotopes; Fluvoxamine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Spiperone; Tissue Distribution; Tomography, Emission-Computed | 2000 |
1 other study(ies) available for 3-n-(2-fluoroethyl)spiperone and Depressive Disorder, Major
| Article | Year |
|---|---|
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Case-Control Studies; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluorine Radioisotopes; Humans; Ligands; Male; Middle Aged; Paroxetine; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Spiperone; Tomography, Emission-Computed | 2003 |